The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 64 , ISSUE 2 ( April-June, 2022 ) > List of Articles


Chronic Respiratory Diseases Burden and Healthcare Facilities

Raj Kumar, David W Denning, Anuradha Chowdhary

Citation Information : Kumar R, Denning DW, Chowdhary A. Chronic Respiratory Diseases Burden and Healthcare Facilities. Indian J Chest Dis Allied Sci 2022; 64 (2):61-62.

DOI: 10.5005/jp-journals-11007-0007

License: CC BY-NC 4.0

Published Online: 08-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


  1. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020; 8(6):585–596. DOI: 10.1016/S2213-2600(20)30105-3.
  2. Hammond EE, McDonald CS, Vestbo J, et al. The global impact of Aspergillus infection on COPD. BMC Pulm Med 2020;20(1):241. DOI: 10.1186/s12890-020-01259-8.
  3. Dodd PJ, Yuen CM, Jayasooriya, SM, et al. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infect Dis 2021;21(7):984–992. DOI: 10.1016/S1473-3099(20)30919-1.
  4. Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis 2017;17(11): e357–e366. DOI: 10.1016/S1473-3099(17)30309-2.
  5. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859): 2163–2196. DOI: 10.1016/S0140-6736(12)61729-2.
  6. India State-Level Disease Burden Initiative CRD Collaborators. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health 2018;6(12):e1363–e1374. DOI: 10.1016/S2214-109X(18)30409-1.
  7. Iqbal N, Amir Sheikh MD, Jabeen K, et al. Allergic bronchopulmonary aspergillosis misdiagnosed as smear negative pulmonary tuberculosis; a retrospective study from Pakistan. Ann Med Surg (Lond). 2021;72:103045. DOI: 10.1016/j.amsu.2021.103045.
  8. Brown GD, Denning DW, Gow NAR, et al. Hidden killers: human fungal infections. Sci Transl Med 2012;4(165):165rv13. DOI: 10.1126/scitranslmed.3004404.
  9. Baker J, Kosmidis C, Rozaliyani A, et al. Chronic pulmonary histoplasmosis: a scoping literature review. Open Forum Infect Dis 2020;7(5):ofaa119. DOI: 10.1093/ofid/ofaa119.
  10. World Health Organization. 3rd Essential Diagnostics List Launch. Available at:
  11. Ashbee HR, Barnes RA, Johnson EM, et al. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother 2014;69(5):1162–1176. DOI: 10.1093/jac/dkt508.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.